Status:
ACTIVE_NOT_RECRUITING
Malnutrition Screening and Dietary Intervention to Improve Nutrition Outcomes in Patients With Unresectable Pancreatic Cancer
Lead Sponsor:
Jonsson Comprehensive Cancer Center
Collaborating Sponsors:
Silicon Valley Community Foundation
Conditions:
Stage III Pancreatic Cancer
Pancreatic Adenocarcinoma Non-resectable
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This clinical trial compares the effect of malnutrition screening and dietary intervention to standard nutrition care on patients with pancreatic cancer that cannot be removed by surgery (unresectable...
Detailed Description
PRIMARY OBJECTIVES: I. To compare the quality of life of subjects after 12 weeks between the intervention group with nutrition optimization with dietary prescription and nutrition support in comparis...
Eligibility Criteria
Inclusion
- Unresectable pancreatic adenocarcinoma, receiving either 1) no chemotherapy, 2) 1st cycle of chemotherapy, or 3) greater than 1 cycle of chemotherapy if the patient's prognosis is greater than 6 months as determined by oncology collaborators
- Life expectancy of greater than 3 months and a Karnofsky performance score of 60 or more
- Adults \>= 18 years old male or female
Exclusion
- Ascites requiring paracentesis for symptom improvement
- Aspartate aminotransferase (AST) or alanine aminotransferase (ALT) values greater than 5 times the upper limit of normal
- Creatinine value greater than 2.0 for men and 1.5 for women
- Uncontrolled pain
- Uncontrolled nausea and vomiting
Key Trial Info
Start Date :
January 17 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 31 2027
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT06090916
Start Date
January 17 2023
End Date
March 31 2027
Last Update
May 13 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UCLA / Jonsson Comprehensive Cancer Center
Los Angeles, California, United States, 90095